IF YOUR EARNINGS ARE MISSED INVESTORS WILL BE PISSED

📦 Waste Management (WM)

• Q2 results: Adjusted EPS $1.92 vs. ~$1.89 estimate; Revenue $6.43 B vs. ~$6.36 B expected—both slightly beat expectations 📈 

• Price target: Average ~$252.60, vs. recent share price near $229–230  .

• Multi-year stock performance: Stable utility-like performer; modest growth, low volatility.

• Analyst view: Generally positive, BUY or HOLD, due to consistent earnings surprises.

• Key fundamentals (approximate, based on typical WM data):

  • P/E: ~22–24×

  • EPS (trailing): around $8

  • P/B: ~4×; P/S: ~3×

  • Dividend yield: ~1.7%; payout ratio: ~30–40%

  • Debt/Equity: moderately high (~1.0)

  • Profit margin: ~10–12%

  • Free cash flow yield: decent steady stream

  
  
  
  

🧴 Procter & Gamble (PG)

• Q2 results: Sales $21.88 B beat ~$21.6–21.9 B estimates; Core EPS ~$1.84–1.88 vs. ~$1.60 expected—solid beat 🤩 .

• Price targets: Average ~$174, with range from $152 to $186; current trading around $155 

• Stock performance: Steady long-term grower with dividend reputation; moderate total returns.

• Analyst view: Consensus is Overweight / Buy—steady consumer staples demand, resilience.

• Key fundamentals:

  • P/E: ~23–25×

  • EPS (trailing): ~$6.5–7

  • P/B: ~7×; P/S: ~3×

  • Dividend yield: ~2.5%; payout ratio: ~60%

  • Debt/Equity: ~0.5–0.7

  • Profit margin: ~18–20%

  • Free cash flow yield: strong, supports dividends and buybacks

🏥 UnitedHealth Group (UNH)

• Q2 results: Adjusted EPS ~$4.06 (vs. ~$4.64 expected); Revenue $111.6 B slightly below ~$111.9 B forecast—miss 😬 

• Outlook cut: Full-year EPS now expected at ≥ $16 vs. prior guide up to ~$30 → investors unhappy

• Stock trend: Shares hit 5-year low and down ~44–50% in 2025 YTD

• Analyst price targets/rating:

  • Still majority Buy / Strong Buy, average 12‑month targets ~$595–$630 

  • Others note caution: average targets have ranged lower (~$358) 

• Analysts summary: Bullish long‑term on fundamentals; short‑term cautious due to cost headwinds.

• Fundamentals (approximate typical for UNH):

  • P/E: ~18–20×

  • EPS (trailing): ~14–15

  • P/B: ~4×; P/S: ~0.8×

  • Dividend yield: ~1.5%; payout ratio: ~25%

  • Debt/Equity: ~0.6

  • Profit margin: ~6‑7%

  • Free cash flow: robust but pressured by rising healthcare costs

  
  

✈️ Boeing (BA)

• Q2 results (ended June 30, 2025): GAAP loss $0.92/share; adjusted loss ~$1.24 vs. expected $1.54—so outperformed earnings expectations. Revenue $22.75 B beat estimates ($21.86 B) thanks to 150 commercial deliveries vs. 92 a year ago 🛫  .

• Stock action: Up ~33% in 2025, recouping earlier losses; modest dip immediately after results 

• Analyst sentiment: Mixed—some call Boeing recovery is ahead of schedule; others warn about labor risk, FAA safety oversight delays 

• Outlook:

  • Near term: cautious; big risks around union strike and regulation.

  • Medium to long term: moderate optimism due to backlog (~$619 B) and delivery ramp-up.

• Fundamental metrics:

  • P/E: negative (loss in trailing earnings)

  • Forward P/E: perhaps ~20–25× if profitable outlook

  • Debt/Equity: high (~5+ due to capital-intensive business)

  • Profit margin: negative currently, improving gradually

  • Free cash flow: recently ~–$200 M vs –$4.3 B prior year

  • No dividend currently

🎵 Spotify (SPOT)

• Q2 results: Premium subscribers added ~8 million (total ~276 M), MAUs ~696 M—user growth beat. But posted a loss of $0.48/share vs profit expected ($2.29/share); Revenue $4.75 B missing ~$5 B expectation—big earnings & revenue miss 😢 

• Q3 guidance: Revenue projected ~$4.86 B vs consensus ~$5.25 B—again lower guidance  .

• Stock reaction: Shares fell ~7% pre-market after results.

• Analyst view: Mixed—bullish on subscribers, but bearish on profitability and margin pressure.

• Fundamentals (latest typical):

  • P/E: negative (still loss‑making)

  • P/S: ~3×

  • Free cash flow: weak

  • Debt/Equity: moderate

  • Profit margin: negative; focus is on scaling subscriber base

🚚 UPS (UPS)

• Q2 2025: Adjusted EPS $1.55/share vs. consensus $1.56 → slight miss; revenue ~$21.2 B vs. ~$20.9 B estimated (beating revenue a bit)

• Market reaction: Stock fell ~9.5% on report; YTD down ~20%

• Analyst views: Mixed – Bernstein says Buy with $133 target; Evercore ISI downgraded to Hold, warning of margin pressure

• Recent trend: Returned +0.5% past month, but weaker volumes, domestic volume down ~7% YOY

• Fundamentals (approximate typical for UPS):

  • P/E: ~18–20×

  • EPS (trailing adjusted): ~$6* (4 qtrs × $1.55 approx)

  • P/S: ~1×

  • Dividend yield: ~4–5% (“rock solid” €5.5 B annual) payout backed by ~$4.5 B expected free cash flow

  • Debt/Equity: moderate (~1)

  • Operating margin: ~8.8%

  • Free cash flow: negative this quarter due to timing issues, but healthy annually

• Rating: Hold to Weak Buy; near‑term bearish/mid‑term cautious, long‑term defensive income play.

🧺 Whirlpool (WHR)

• Q2: Adjusted EPS $1.34/share vs. $1.68 expected → big miss, sales $3.77 B vs. $3.85 B estimated → revenue miss ~5% decline YOY

• Actions: Cut dividend from $1.75 to $0.90, lowered full-year adjusted EPS to $6–8 (vs. previous ~$10)

• Stock: Down 12% on release, underperforming the S&P 500 YTD (+9%)

• Analysts: Concerned about import stockpiling from Asian rivals ahead of tariffs; cost controls underway

• Fundamentals:

  • P/E: ~10–12× based on new lower EPS

  • EPS (adj trailing): ~$12.21 in 2024; 2025 ongoing guidance ~$10 estimated

  • P/S: ~0.7×–1×

  • Dividend yield: now ~1–2% (cut)

  • Debt/Equity: moderate

  • EBIT margin: ~5–6% ongoing guidance

  • Free cash flow: projected $500–600 M in 2025

• Rating: Defensive—Hold or cautious low Buy, short‑term bearish, long‑term mixed recovery if tariffs stabilize.

💊 Novo Nordisk (NVO)

• Reaction: Shares plunged ~21–23% after cutting full-year 2025 sales growth to 8‑14% (from 13‑21%) and profit growth to 10‑16% (from 16‑24%) due to competitive pressure from Eli Lilly and copycat drugs

• Leadership: New CEO Maziar Mike Doustdar appointed to counter U.S. competition

• Analysts: Mixed; some say drop is overreaction given pipeline potential; others bearish on long‑term growth prospects amid pricing conflicts

• Fundamentals:

  • P/E: ~25–30× before plunge, now ~15–20× adjusted

  • EPS trailing: robust; dividend yield ~3%

  • Debt/Equity: low (~0.3)

  • Profit margin: ~30‑35% pre‑guidance cut

  • P/S: ~6–8×

• Rating: Short‑term bearish; mid‑term cautious; long‑term depends on legal/regulatory wins—Hold or Weak Buy at deep discount.

🧠 Bottom Line for Young Investors:

• Waste Management & P&G are stable, dividend‑paying, everyday giants. Good if you want less risk and steady returns.

• UnitedHealth has serious cost issues hitting near‑term performance, but remains a long‑term play if healthcare stabilizes.

• Boeing is still recovering—if you’re ok with volatility and a roller‑coaster path, it might rebound as deliveries ramp up.

• Spotify is growing subscribers nicely, but still not turning a profit—best suited for high‑risk, high‑growth investors

• UPS = safe-ish but boring income play

• Whirlpool = cheap but risky turnaround story

• Novo Nordisk = strong biz hit by big sell-off, long-term potential